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Peritoneal dialysis in Mexico. While Mexico has the thirteenth purchasing power (15% of the total population) have
largest economy, a large portion of the population is impover- access to private medicine (via private insurance or on
ished. About 90% of the population is Mestizo, the result of a fee-for-service basis), whereas people with less pur-the admixture of Mexican Indians and Spaniards, with the
chasing power are entitled to social security (40%;Indigenous peoples concentrated in the southeastern region.
provided by the Social Security Institutes), and thoseTreatment for end-stage renal disease (estimated 268 patients
per million population) is largely determined by the limited living in poverty (the remaining 45%) only have access
healthcare system and the individual’s access to resources such to the basic medical services provided by the Health
as private insurance (15%) and governmental sources (85%). Secretariat [2]. Thus, end-stage renal disease (ESRD)With only 5% of the gross national product spent on healthcare
treatment is largely determined by the limitations of theand most treatment providers being public health institutions
health care system. Dialysis supply is not restricted inthat are often under severe economic restrictions, it is not
surprising that many Mexican patients do not receive renal the private sector. There are some restrictions and limita-
replacement therapy. Mexico uses proportionately more peri- tions in the social security system, where the funding is
toneal dialysis than other countries; 1% of the patients are on
subject to annual budgetary considerations. The dialysisautomated peritoneal dialysis, 19% on hemodialysis and 80%
treatment provided by the Health Secretariat has theon CAPD. Malnutrition and diabetes, important risk factors
for poor outcome, are prevalent among the patients in CAPD most severe limitations and is very restricted because of
programs. economic constraints.
ESRD EPIDEMIOLOGICAL DATAMexico is a country of inequities. According to the
According to the National Institute of Statistics, In-World Bank, Mexico is the world’s thirteenth largest
economy, eighth largest exporter of goods and services, formatics and Geography (INEGI), there were 97.5 mil-
and fourth-largest oil producer [1]. The gross national lion people living in Mexico in the year 2000. Of these,
product per capita ($5080 US), however, has not in- only 6.04 million (6.2%) are considered to be Indigenous.
creased in the same proportion. Education and public The vast majority of people in Mexico (about 90%) are
services are problems that have not been completely Mestizos, the result of the admixture between Spaniards
resolved: 10% of people aged 15 years are illiterate, and Mexican Indians. The Indigenous people are concen-
21% of Mexican homes do not have sewerage, 10% do trated in southeastern Mexico (Oaxaca, Chiapas, Vera-
not have drinking water on tap, and 5% do not have cruz and Yucata´n states), the poorest region in the coun-
an electricity supply [2]. Therefore, while the macro- try. No reliable data about national ESRD epidemiology
economy seems to have been appropriately developed are available in Mexico; however, in the state of Jalisco
in recent years, many problems in the micro-economy (in the west of Mexico) data are incorporated with the
have not been fully addressed. Registry of Dialysis and Transplantation (REDTJAL)
[3]. This state registry holds complete data relating to
renal replacement therapy since 1998 and has been theHEALTH CARE AND DIALYSIS SUPPLY
basis for the Mexican data appearing in the latest reports
Health care is another unsolved problem. As in many of the Latin American Society of Nephrology and Hyper-
countries, in Mexico this issue is closely related to the tension [4]. According to the latter, the prevalence of
individual’s purchasing power. Those with the highest ESRD in Mexico was 268 patients per million in 1999.
These data do not mean that Mexico has a lower ESRD
prevalence than developed countries or other LatinKey words: Latin American nephropathy, dialysis in Mexico, end-stage
American countries, such as Puerto Rico, Uruguay, Chilerenal disease, chronic renal disease, Mestizos, diabetes mellitus, malnu-
trition. or Argentina. Rather, this reflects the limited availability
of renal replacement therapy (Fig. 1). Thus, it is not 2003 by the International Society of Nephrology
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Fig. 1. Prevalence of end-stage renal disease (ESRD) in Latin America. (Modified from [4], and used with permission from the Sociedad Latino
Americana de Nefrologia e Hipertension)
surprising that countries with low incomes tend to report (CAPD). It is expected that, on conservative calculations
(with respect to the present growth rate), there will bea low prevalence of renal failure prevalence. According
to the Pan American Health Organization, developing 75,000 patients on dialysis programs by the year 2010.
The treatment of these patients will present a great chal-countries such as Mexico spend only 5% of their gross
national product on health, whereas developed countries lenge for the economically limited health institutions
within Mexico.such as the United States or Canada spend up to 14%
of their gross national product on health [5]. Moreover,
in absolute terms, the gross national product of Mexico
CAPD OUTCOMEis lower than the amount spent only on health care in
Two important conditions in the Mexican CAPD pop-the United States [5]. If we further consider that ESRD
ulation require special attention: diabetes mellitus andtreatment in Mexico is provided by public health care
malnutrition.institutions (which have important economic limita-
Diabetes mellitus (about 90% is type 2 in Mexico)tions), it is not surprising that many Mexican patients
causes about 40% of ESRD in Mexico. Other causeswith ESRD do not receive renal replacement therapy.
are: unknown etiology (31%), chronic glomerulonephri-
tis (14%), polycystic renal disease (6%), nephrosclerosis
ESRD TREATMENT (4%), and others (5%) [3]. This is particularly worrying,
considering that Mexicans and individuals of MexicanIt is broadly known that Mexico is the country that
uses proportionally more peritoneal dialysis than other origin living in other countries (such as, Mexican Ameri-
cans) seem to have a higher prevalence of diabetes melli-nations. In 1990, Mexico employed peritoneal dialysis in
90% of ESRD patients [6]. Nine years later, the most tus than other populations, around 10% [7, 8] and 25%
[9, 10], respectively. In addition to this high prevalence,recent data show that the use of peritoneal dialysis has
been reduced to 81% [4]. This is still the greatest use of diabetes mellitus, in conjunction with hypoalbuminemia-
malnutrition, old age, lymphopenia, and a high perito-peritoneal dialysis reported worldwide.
According to commercial sources (Laboratorios Pisa, neal transport rate, are the most significant risk factors
for mortality identified in the Mexican population onSA de CV) there are 25,000 patients currently on chronic
dialysis in Mexico, and, in agreement with the most re- CAPD [11, 12]. From multivariate analysis, diabetes is
the most significant predictor of mortality. This is notcent REDTJAL Report [3], 19% of these patients are
on hemodialysis, 1% on automated peritoneal dialysis, surprising, as it is well known that diabetics have multiple
comorbid conditions that may negatively affect outcomeand 80% on continuous ambulatory peritoneal dialysis
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Table 1. Some of the most important predictors for mortality economy in the world, but has a high prevalence of pov-
in CAPD Mexican patients (modified from [11])
erty. Mexico continues to be the country with propor-
Non-diabetics Diabetics tionally the largest utilization of CAPD in the world.
Variable (N  102) (N  65) P value Malnutrition and diabetes mellitus are highly prevalent
Age years 38.315.4 55.413.3 0.0001 in Mexican patients on CAPD programs, and these con-
Serum albumin g/dL 3.200.70 2.840.57 0.001 ditions are important risk factors for a poor outcome.Serum creatinine mg/dL 10.84.1 7.062.9 0.0001
Creatinine D/P ratio 0.670.11 0.710.12 0.03
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in CAPD. These include old age, hypoalbuminemia, low
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